|
GB9206861D0
(en)
|
1992-03-28 |
1992-05-13 |
Univ Manchester |
Wound healing and treatment of fibrotic disorders
|
|
US20030198642A1
(en)
|
1995-08-03 |
2003-10-23 |
Johannes J. Geuze |
Cell derived antigen presenting vesicles
|
|
AR014195A1
(es)
|
1997-12-29 |
2001-02-07 |
Ortho Mcneil Pharm Inc |
Compuestos de trifenilpropanamida utiles para el tratamiento de procesos inflamatorios, composiciones anti-inflamatorias que los comprenden, ymetodos para prepararlos
|
|
MY132496A
(en)
|
1998-05-11 |
2007-10-31 |
Vertex Pharma |
Inhibitors of p38
|
|
US6413556B1
(en)
|
1999-01-08 |
2002-07-02 |
Sky High, Llc |
Aqueous anti-apoptotic compositions
|
|
US6372494B1
(en)
*
|
1999-05-14 |
2002-04-16 |
Advanced Tissue Sciences, Inc. |
Methods of making conditioned cell culture medium compositions
|
|
GB9927320D0
(en)
|
1999-11-18 |
2000-01-12 |
Chiron Spa |
Exosome separation
|
|
ATE521353T1
(de)
|
2000-10-23 |
2011-09-15 |
Glaxosmithkline Llc |
Neues trisubstitutiertes 8h-pyridoä2,3- düpyrimidin-7-onderivat zur behandlung von durch csbp/p38kinase vermittelten krankheiten
|
|
AU2001297880B2
(en)
*
|
2000-11-30 |
2007-05-31 |
Stemron Inc. |
Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
|
|
GB0117583D0
(en)
|
2001-07-19 |
2001-09-12 |
Astrazeneca Ab |
Novel compounds
|
|
KR100519384B1
(ko)
|
2002-08-13 |
2005-10-06 |
(주)누백스 |
유전자 이입을 이용한 엑소좀의 제조방법 및 상기 엑소좀의 용도
|
|
US7144999B2
(en)
|
2002-11-23 |
2006-12-05 |
Isis Pharmaceuticals, Inc. |
Modulation of hypoxia-inducible factor 1 alpha expression
|
|
US8021847B2
(en)
|
2004-06-02 |
2011-09-20 |
Proxy Life Science Holdings, Inc. |
Microvesicle-based compositions and methods
|
|
WO2005121369A2
(en)
*
|
2004-06-02 |
2005-12-22 |
Sourcepharm, Inc. |
Rna-containing microvesicles and methods therefor
|
|
KR20070058441A
(ko)
|
2004-07-01 |
2007-06-08 |
유니버시티 오브 피츠버그 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 |
면역억제성 엑소솜
|
|
AU2006202209B2
(en)
|
2005-05-27 |
2011-04-14 |
Lifescan, Inc. |
Amniotic fluid derived cells
|
|
US8637005B2
(en)
|
2005-11-07 |
2014-01-28 |
Amorcyte, Inc. |
Compositions and methods of vascular injury repair
|
|
CA3061952C
(en)
|
2006-03-09 |
2022-07-19 |
Aethlon Medical, Inc. |
Extracorporeal removal of microvesicular particles
|
|
US9085778B2
(en)
|
2006-05-03 |
2015-07-21 |
VL27, Inc. |
Exosome transfer of nucleic acids to cells
|
|
CA2657030A1
(en)
|
2006-07-13 |
2008-01-17 |
The Ohio State University Research Foundation, An Instrumentality Of The State Of Ohio |
Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases
|
|
EP1939218A1
(en)
|
2006-12-29 |
2008-07-02 |
Thrombotargets Europe, S.L. |
Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof
|
|
WO2008112125A1
(en)
|
2007-03-09 |
2008-09-18 |
Merck & Co., Inc. |
Papillomavirus vaccine compositions
|
|
EP2719773A3
(en)
|
2007-06-15 |
2014-07-30 |
The Ohio State University Research Foundation |
miRNA as marker for acute lamphomic leucemia
|
|
WO2009015357A1
(en)
|
2007-07-25 |
2009-01-29 |
University Of Louisville Research Foundation, Inc. |
Exosome-associated microrna as a diagnostic marker
|
|
US20100255514A1
(en)
*
|
2007-08-16 |
2010-10-07 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
Tumor cell-derived microvesicles
|
|
EP2209481B1
(en)
*
|
2007-10-15 |
2013-03-13 |
Fresenius Medical Care Deutschland GmbH |
Use of microvesicles (mvs) for preparing a medicament having adjuvant activity on endothelial cell transplantation, particularly in the treatment of diabetes by pancreatic islet transplantation, and related method
|
|
ES2523098T3
(es)
*
|
2007-10-29 |
2014-11-20 |
Fresenius Medical Care Deutschland Gmbh |
Microvesícula (MV) derivada de células madre para su uso en la inhibición de la apoptosis inducida por un agente citostático
|
|
CA2711218C
(en)
|
2008-01-04 |
2019-08-06 |
Lydac Neuroscience Limited |
A method of producing a population of differentiated cells
|
|
US8617806B2
(en)
|
2008-01-25 |
2013-12-31 |
Hansabiomed Ou |
Method to measure and characterize microvesicles in the human body fluids
|
|
US20120058492A1
(en)
|
2008-01-25 |
2012-03-08 |
Hansabiomed Ou |
Method and a Kit To Detect Malignant Tumors and Provide a Prognosis
|
|
EP2245199B1
(en)
*
|
2008-02-01 |
2013-11-13 |
The General Hospital Corporation |
Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions
|
|
CN102014934B
(zh)
|
2008-02-22 |
2014-08-20 |
新加坡科技研究局 |
间充质干细胞颗粒
|
|
FR2928926B1
(fr)
|
2008-03-18 |
2015-08-21 |
Centre Nat Rech Scient |
Polynucleotides et polypeptides chimeriques permettant la secretion d'un polypeptide d'interet en association avec des exosomes et leur utilisation pour la production de compositions immunogenes
|
|
AU2009236653B2
(en)
*
|
2008-04-16 |
2014-09-25 |
Biogen Ma Inc. |
Method of isolating biomacromolecules using polyalkylene glycol and transition metals
|
|
US10545149B2
(en)
|
2008-10-06 |
2020-01-28 |
Morehouse School Of Medicine |
Detection of HIV-related proteins in urine
|
|
US8512695B2
(en)
|
2008-10-21 |
2013-08-20 |
The General Hospital Corporation |
Method of preventing fat graft resorption by administering fat-derived cells and poloxamer P 188
|
|
GB2463401B
(en)
|
2008-11-12 |
2014-01-29 |
Caris Life Sciences Luxembourg Holdings S A R L |
Characterizing prostate disorders by analysis of microvesicles
|
|
SG172983A1
(en)
|
2009-01-15 |
2011-08-29 |
Lab Corp America Holdings |
Methods of determining patient response by measurement of her-3
|
|
EP3427755B1
(en)
|
2009-04-13 |
2020-10-21 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Hpv particles and uses thereof
|
|
EP3569254B1
(en)
|
2009-04-17 |
2022-07-20 |
Oxford University Innovation Limited |
Composition for delivery of genetic material
|
|
BRPI0900815A2
(pt)
|
2009-04-23 |
2010-12-28 |
Sociedade Benef Israelita Bras Hospital Albert Einstein |
método para isolamento de exossomos a partir de soluções biológicas utilizando nanopartìculas de óxido de ferro
|
|
MX2011013452A
(es)
|
2009-07-02 |
2012-04-30 |
Ith Immune Therapy Holdings Ab |
Tratamiento de cancer basado en exosomas.
|
|
BR112012001077A2
(pt)
*
|
2009-07-16 |
2020-08-11 |
The General Hospital Corporation |
extração de ácido nucleico, métodos para avaliar a qualidade de uma extração de ácido nucleico e de uma amostra biológica, para ober ácido nucleico a partir de uma amostra biológica, para analisar rna de microvesículas e para diagnosticar e monitorar um indivíduo, e, kit
|
|
CN102812362B
(zh)
|
2010-01-08 |
2015-02-11 |
卡瓦迪斯有限责任公司 |
用于预测心血管事件的外来体生物标志物的确定
|
|
WO2011097480A1
(en)
|
2010-02-05 |
2011-08-11 |
University Of Louisville Research Foundation, Inc. |
Exosomal compositions and methods for the treatment of disease
|
|
CN103079592B
(zh)
*
|
2010-07-01 |
2015-10-21 |
浦项工科大学校产学协力团 |
使用来自细胞的微泡治疗和诊断癌症的方法
|
|
CA2845280A1
(en)
*
|
2010-08-13 |
2012-02-16 |
Paul Shiels |
Therapeutic uses of microvesicles and related micrornas
|
|
US20120053976A1
(en)
|
2010-08-31 |
2012-03-01 |
Xerox Corporation |
System and method for determining whether service costs can be reduced
|
|
JP5911874B2
(ja)
*
|
2010-10-18 |
2016-04-27 |
エージェンシー フォー サイエンス，テクノロジー アンド リサーチ |
発毛を促進又は増強するためのエキソソームの使用
|
|
US20120093885A1
(en)
*
|
2010-10-18 |
2012-04-19 |
Northwestern University |
Therapeutic vesicles
|
|
SG183579A1
(en)
|
2011-02-11 |
2012-09-27 |
Agency Science Tech & Res |
Methods of detecting therapeutic exosomes
|
|
WO2012110253A2
(en)
|
2011-02-18 |
2012-08-23 |
Cavadis B.V. |
Exosomal biomarkers for cardiovascular events
|
|
WO2012110099A1
(en)
|
2011-02-18 |
2012-08-23 |
Cavadis B.V. |
Determination of exosomal biomarkers for predicting cardiovascular events
|
|
WO2012126531A1
(en)
|
2011-03-24 |
2012-09-27 |
Cavadis B.V. |
Method for diagnosing acute coronary syndrome (acs)
|
|
WO2012135844A2
(en)
|
2011-04-01 |
2012-10-04 |
Cornell University |
Circulating exosomes as diagnostic/prognostic indicators and therapeutic targets of melanoma and other cancers
|
|
SG195306A1
(en)
|
2011-06-08 |
2013-12-30 |
Agency Science Tech & Res |
Purification of biological products by constrained cohydration chromatography
|
|
EP2734543B1
(en)
|
2011-07-24 |
2018-10-03 |
Carmel-Haifa University Economic Corp. |
Lactoferrin fragments and use thereof
|
|
ITRM20110403A1
(it)
*
|
2011-07-28 |
2013-01-29 |
Ospedale Pediatrico Bambino Gesu |
Microvescicole isolate da cellule mesenchimali come agenti immunosoppressori.
|
|
CN103842522A
(zh)
|
2011-08-05 |
2014-06-04 |
路易斯维尔大学研究基金会 |
微rna生物标记物
|
|
EP2604288A1
(en)
|
2011-12-16 |
2013-06-19 |
Biocant - Associação De Transferência De Tecnologia |
Nanoparticles and uses thereof
|
|
US20150052361A1
(en)
|
2011-12-23 |
2015-02-19 |
Appbyyou Gmbh |
Method for setting up an encrypted connection between two communication appliances following prior key interchange via a shorthaul connection
|
|
US20130273544A1
(en)
|
2012-04-17 |
2013-10-17 |
Life Technologies Corporation |
Methods and compositions for exosome isolation
|
|
US9005888B2
(en)
|
2012-06-14 |
2015-04-14 |
System Biosciences, Llc |
Methods for microvesicle isolation and selective removal
|
|
WO2013188832A1
(en)
|
2012-06-14 |
2013-12-19 |
System Biosciences, Llc |
Methods for microvesicle isolation and selective removal
|
|
EP2687219A1
(en)
*
|
2012-07-18 |
2014-01-22 |
Universität Duisburg-Essen |
Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions
|
|
AU2013302799B2
(en)
|
2012-08-13 |
2018-03-01 |
Cedars-Sinai Medical Center |
Exosomes and micro-ribonucleic acids for tissue regeneration
|
|
ES2686129T3
(es)
|
2012-11-13 |
2018-10-16 |
Codiak Biosciences, Inc. |
Administración de agentes terapéuticos
|
|
US12558316B2
(en)
|
2013-03-13 |
2026-02-24 |
University Of Miami |
Methods and compositions for the treatment of epidermolysis bullosa
|
|
CN105209881B
(zh)
|
2013-03-13 |
2021-01-22 |
迈阿密大学 |
从细胞培养上清液和生物流体分离并纯化微泡的方法
|
|
SG11201601939VA
(en)
|
2013-09-16 |
2016-04-28 |
Agency Science Tech & Res |
Method
|
|
US20170173113A1
(en)
|
2014-03-13 |
2017-06-22 |
Research Institute At Nationwide Children's Hospital |
Methods of delivering heparin binding epidermal growth factor using stem cell generated exosomes
|
|
EP3193890A4
(en)
|
2014-09-15 |
2018-03-14 |
Agency For Science, Technology And Research |
Methods of treating graft versus host disease (gvhd) or epidermolysis bullosa (eb) with exosomes
|
|
WO2016172598A1
(en)
|
2015-04-22 |
2016-10-27 |
The Broad Institute Inc. |
Exosomes and uses thereof
|
|
US10751412B2
(en)
|
2015-05-29 |
2020-08-25 |
Merck Sharp & Dohme Corp. |
Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancer
|
|
KR20170085010A
(ko)
|
2016-01-12 |
2017-07-21 |
주식회사 강스템바이오텍 |
고함량의 성장인자를 함유한 줄기세포 유래 엑소좀
|
|
EP3922253A1
(en)
|
2016-01-15 |
2021-12-15 |
Orbsen Therapeutics Limited |
Sdc-2 exosome compositions and methods of isolation and use
|
|
CA3076610A1
(en)
|
2017-09-22 |
2019-03-28 |
University Of Miami |
Methods and compositions for the treatment of epidermolysis bullosa
|
|
KR20230074475A
(ko)
|
2020-08-21 |
2023-05-30 |
더 유니버시티 오브 마이애미 |
골수-유래 중간엽 줄기 세포로부터의 미세소포를 사용한 치료의 조성물 및 방법
|